Home Healthcare IT Irritable Bowel Syndrome Treatment Market Size & Growth | 2033

Irritable Bowel Syndrome Treatment Market Size & Outlook, 2025-2033

Irritable Bowel Syndrome Treatment Market Size, Share & Trends Analysis Report By Product (Rifaximin, Eluxadoline, Lubiprostone, Linaclotide, Others), By Type (IBS with Diarrhea (IBS-D), IBS with Constipation (IBS-C), Mixed IBS), By Distribution Channel (Hospitals pharmacies, Drug Stores and Retail Pharmacies, Online pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI55444DR
Last Updated : May, 2025
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Market Segmentation

  1. Irritable Bowel Syndrome Treatment Market, By Product (2021-2033)
    1. Rifaximin
    2. Eluxadoline
    3. Lubiprostone
    4. Linaclotide
    5. Others
  2. Irritable Bowel Syndrome Treatment Market, By Type (2021-2033)
    1. IBS with Diarrhea (IBS-D)
    2. IBS with Constipation (IBS-C)
    3. Mixed IBS
  3. Irritable Bowel Syndrome Treatment Market, By Distribution Channel (2021-2033)
    1. Hospitals pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online pharmacies
    1. North America
      1. North America Irritable Bowel Syndrome Treatment Market, By Product
        1. Rifaximin
          1. Eluxadoline
            1. Lubiprostone
              1. Linaclotide
                1. Others
                2. North America Irritable Bowel Syndrome Treatment Market, By Type
                  1. IBS with Diarrhea (IBS-D)
                    1. IBS with Constipation (IBS-C)
                      1. Mixed IBS
                      2. North America Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                        1. Hospitals pharmacies
                          1. Drug Stores and Retail Pharmacies
                            1. Online pharmacies
                            2. U.S.
                              1. U.S. Irritable Bowel Syndrome Treatment Market, By Product
                                1. Rifaximin
                                  1. Eluxadoline
                                    1. Lubiprostone
                                      1. Linaclotide
                                        1. Others
                                        2. U.S. Irritable Bowel Syndrome Treatment Market, By Type
                                          1. IBS with Diarrhea (IBS-D)
                                            1. IBS with Constipation (IBS-C)
                                              1. Mixed IBS
                                              2. U.S. Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                1. Hospitals pharmacies
                                                  1. Drug Stores and Retail Pharmacies
                                                    1. Online pharmacies
                                                  2. Canada
                                                2. Europe
                                                  1. Europe Irritable Bowel Syndrome Treatment Market, By Product
                                                    1. Rifaximin
                                                      1. Eluxadoline
                                                        1. Lubiprostone
                                                          1. Linaclotide
                                                            1. Others
                                                            2. Europe Irritable Bowel Syndrome Treatment Market, By Type
                                                              1. IBS with Diarrhea (IBS-D)
                                                                1. IBS with Constipation (IBS-C)
                                                                  1. Mixed IBS
                                                                  2. Europe Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                    1. Hospitals pharmacies
                                                                      1. Drug Stores and Retail Pharmacies
                                                                        1. Online pharmacies
                                                                        2. U.K.
                                                                          1. U.K. Irritable Bowel Syndrome Treatment Market, By Product
                                                                            1. Rifaximin
                                                                              1. Eluxadoline
                                                                                1. Lubiprostone
                                                                                  1. Linaclotide
                                                                                    1. Others
                                                                                    2. U.K. Irritable Bowel Syndrome Treatment Market, By Type
                                                                                      1. IBS with Diarrhea (IBS-D)
                                                                                        1. IBS with Constipation (IBS-C)
                                                                                          1. Mixed IBS
                                                                                          2. U.K. Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                            1. Hospitals pharmacies
                                                                                              1. Drug Stores and Retail Pharmacies
                                                                                                1. Online pharmacies
                                                                                              2. Germany
                                                                                              3. France
                                                                                              4. Spain
                                                                                              5. Italy
                                                                                              6. Russia
                                                                                              7. Nordic
                                                                                              8. Benelux
                                                                                              9. Rest of Europe
                                                                                            2. APAC
                                                                                              1. APAC Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                1. Rifaximin
                                                                                                  1. Eluxadoline
                                                                                                    1. Lubiprostone
                                                                                                      1. Linaclotide
                                                                                                        1. Others
                                                                                                        2. APAC Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                          1. IBS with Diarrhea (IBS-D)
                                                                                                            1. IBS with Constipation (IBS-C)
                                                                                                              1. Mixed IBS
                                                                                                              2. APAC Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                1. Hospitals pharmacies
                                                                                                                  1. Drug Stores and Retail Pharmacies
                                                                                                                    1. Online pharmacies
                                                                                                                    2. China
                                                                                                                      1. China Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                                        1. Rifaximin
                                                                                                                          1. Eluxadoline
                                                                                                                            1. Lubiprostone
                                                                                                                              1. Linaclotide
                                                                                                                                1. Others
                                                                                                                                2. China Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                                                  1. IBS with Diarrhea (IBS-D)
                                                                                                                                    1. IBS with Constipation (IBS-C)
                                                                                                                                      1. Mixed IBS
                                                                                                                                      2. China Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                                        1. Hospitals pharmacies
                                                                                                                                          1. Drug Stores and Retail Pharmacies
                                                                                                                                            1. Online pharmacies
                                                                                                                                          2. Korea
                                                                                                                                          3. Japan
                                                                                                                                          4. India
                                                                                                                                          5. Australia
                                                                                                                                          6. Singapore
                                                                                                                                          7. Taiwan
                                                                                                                                          8. South East Asia
                                                                                                                                          9. Rest of Asia-Pacific
                                                                                                                                        2. Middle East and Africa
                                                                                                                                          1. Middle East and Africa Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                                                            1. Rifaximin
                                                                                                                                              1. Eluxadoline
                                                                                                                                                1. Lubiprostone
                                                                                                                                                  1. Linaclotide
                                                                                                                                                    1. Others
                                                                                                                                                    2. Middle East and Africa Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                                                                      1. IBS with Diarrhea (IBS-D)
                                                                                                                                                        1. IBS with Constipation (IBS-C)
                                                                                                                                                          1. Mixed IBS
                                                                                                                                                          2. Middle East and Africa Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                                                            1. Hospitals pharmacies
                                                                                                                                                              1. Drug Stores and Retail Pharmacies
                                                                                                                                                                1. Online pharmacies
                                                                                                                                                                2. UAE
                                                                                                                                                                  1. UAE Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                                                                                    1. Rifaximin
                                                                                                                                                                      1. Eluxadoline
                                                                                                                                                                        1. Lubiprostone
                                                                                                                                                                          1. Linaclotide
                                                                                                                                                                            1. Others
                                                                                                                                                                            2. UAE Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                                                                                              1. IBS with Diarrhea (IBS-D)
                                                                                                                                                                                1. IBS with Constipation (IBS-C)
                                                                                                                                                                                  1. Mixed IBS
                                                                                                                                                                                  2. UAE Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                                                                                    1. Hospitals pharmacies
                                                                                                                                                                                      1. Drug Stores and Retail Pharmacies
                                                                                                                                                                                        1. Online pharmacies
                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                      1. LATAM Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                                                                                                        1. Rifaximin
                                                                                                                                                                                          1. Eluxadoline
                                                                                                                                                                                            1. Lubiprostone
                                                                                                                                                                                              1. Linaclotide
                                                                                                                                                                                                1. Others
                                                                                                                                                                                                2. LATAM Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                                                                                                                  1. IBS with Diarrhea (IBS-D)
                                                                                                                                                                                                    1. IBS with Constipation (IBS-C)
                                                                                                                                                                                                      1. Mixed IBS
                                                                                                                                                                                                      2. LATAM Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                                                                                                        1. Hospitals pharmacies
                                                                                                                                                                                                          1. Drug Stores and Retail Pharmacies
                                                                                                                                                                                                            1. Online pharmacies
                                                                                                                                                                                                            2. Brazil
                                                                                                                                                                                                              1. Brazil Irritable Bowel Syndrome Treatment Market, By Product
                                                                                                                                                                                                                1. Rifaximin
                                                                                                                                                                                                                  1. Eluxadoline
                                                                                                                                                                                                                    1. Lubiprostone
                                                                                                                                                                                                                      1. Linaclotide
                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                        2. Brazil Irritable Bowel Syndrome Treatment Market, By Type
                                                                                                                                                                                                                          1. IBS with Diarrhea (IBS-D)
                                                                                                                                                                                                                            1. IBS with Constipation (IBS-C)
                                                                                                                                                                                                                              1. Mixed IBS
                                                                                                                                                                                                                              2. Brazil Irritable Bowel Syndrome Treatment Market, By Distribution Channel
                                                                                                                                                                                                                                1. Hospitals pharmacies
                                                                                                                                                                                                                                  1. Drug Stores and Retail Pharmacies
                                                                                                                                                                                                                                    1. Online pharmacies
                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                              Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                              Get This Report

                                                                                                                                                                                                                              Download Free Sample

                                                                                                                                                                                                                              Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                              The button will be active once the above form is filled

                                                                                                                                                                                                                              Our Clients:

                                                                                                                                                                                                                              LG Electronics
                                                                                                                                                                                                                              AMCAD Engineering
                                                                                                                                                                                                                              KOBE STEEL LTD.
                                                                                                                                                                                                                              Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                              Voith Group
                                                                                                                                                                                                                              International Paper
                                                                                                                                                                                                                              Hansol Paper
                                                                                                                                                                                                                              Whirlpool Corporation
                                                                                                                                                                                                                              Sony
                                                                                                                                                                                                                              Samsung Electronics
                                                                                                                                                                                                                              Qualcomm
                                                                                                                                                                                                                              Google
                                                                                                                                                                                                                              Fiserv
                                                                                                                                                                                                                              Veto-Pharma
                                                                                                                                                                                                                              Nippon Becton Dickinson
                                                                                                                                                                                                                              Merck
                                                                                                                                                                                                                              Argon Medical Devices
                                                                                                                                                                                                                              Abbott
                                                                                                                                                                                                                              Ajinomoto
                                                                                                                                                                                                                              Denon
                                                                                                                                                                                                                              Doosan
                                                                                                                                                                                                                              Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                              LG Chemicals
                                                                                                                                                                                                                              LCY chemical group
                                                                                                                                                                                                                              Bayer
                                                                                                                                                                                                                              Airrane
                                                                                                                                                                                                                              BASF
                                                                                                                                                                                                                              Toyota Industries
                                                                                                                                                                                                                              Nissan Motors
                                                                                                                                                                                                                              Neenah
                                                                                                                                                                                                                              Mitsubishi
                                                                                                                                                                                                                              Hyundai Motor Company

                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                              Address:
                                                                                                                                                                                                                              Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                              Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                              Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                              Contact Us:
                                                                                                                                                                                                                              +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                              +91 8087085354 (India)
                                                                                                                                                                                                                              +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                              sales@straitsresearch.com

                                                                                                                                                                                                                              Quick Links
                                                                                                                                                                                                                              Help
                                                                                                                                                                                                                              Verified. Protected. Secure.
                                                                                                                                                                                                                              DMCA.com Protection Status
                                                                                                                                                                                                                              Secure Payments:
                                                                                                                                                                                                                              Follow Us:
                                                                                                                                                                                                                              www.straitsresearch.com © Copyright . All rights Reserved.